Comparing algorithms that search for cancer mutations

July 17, 2017, Sanford-Burnham Prebys Medical Discovery Institute
Adam Godzik, Ph.D., is director of the Bioinformatics and Structural Biology Program at Sanford Burnham Prebys Medical Discovery Institute. Credit: Bil Zelman

Sanford Burnham Prebys Medical Discovery Institute (SBP) has undertaken the first-ever comparative analysis of a newly emerging category of algorithms that mine genetic information in cancer databases by focusing on internal gene structure (subgene resolution algorithms), in contrast to classical approaches that focus on genes treated as single units. These powerful data-sifting tools are helping untangle the complexity of cancer, and find previously unidentified mutations that are important in creating cancer cells.

The study, published today in Nature Methods, reviews, classifies and describes the strengths and weaknesses of more than 20 algorithms developed by independent research groups.

"Despite the increasing availability of high-resolution genome sequences, a common assumption is to consider a gene as a single unit," explains Adam Godzik, Ph.D., director of the Bioinformatics and Structural Biology Program at SBP, and senior author of the study. "However, there are a number of events, such as single site DNA substitutions and splicing variants that can occur within a gene—at the subgene level. Subgene algorithms provide a high-resolution view that can explain why different in the same gene can lead to distinct phenotypes, depending on how they impact specific protein regions.

"A good example of how different subgene mutations influence cancer is the NOTCH1 gene," says Godzik. "Mutations in certain regions of NOTCH1 cause it to act as a tumor suppressor in lung, skin and head and neck cancers. But mutations in a different region can promote chronic lymphocytic leukemia and T cell acute lymphoblastic leukemia. So it's incorrect to assume that mutations in a gene will have the same consequences regardless of their location."

The study researchers applied each subgene to the data from The Cancer Genome Atlas (TCGA), a large-scale data set that includes genome data from 33 different tumor types from more than 11,000 patients.

"Our goal was not to determine which algorithm works better than another, because that would depend on the question being asked," says Eduard Porta-Pardo, Ph.D., a former postdoc in Godzik's lab and first author of the paper who is now a staff scientist in the Barcelona Supercomputer Center. "Instead, we want to inform potential users about how the different assumptions behind each subgene algorithm influence the results, and how the results differ from methods that work at the whole gene level."

"We found two important things," says Porta-Pardo. "First, we found that the algorithms are able to reproduce the list of known cancer genes established by cancer researchers—validating the subgene approach and the link between these genes and cancer. Second, we found a number of new cancer driver genes—genes implicated in the process of oncogenesis—that were missed by whole-gene approaches.

"Finding new cancer driver is an important goal of cancer genome analysis," adds Porta-Pardo. "This study should help researchers understand the advantages and drawbacks of subgene algorithms used to find new potential drug targets for treatment."

Explore further: 'Big Data' used to identify new cancer driver genes

More information: Eduard Porta-Pardo et al, Comparison of algorithms for the detection of cancer drivers at subgene resolution, Nature Methods (2017). DOI: 10.1038/nmeth.4364

Related Stories

'Big Data' used to identify new cancer driver genes

October 20, 2015
In a collaborative study led by Sanford Burnham Prebys Medical Discovery Institute (SBP), researchers have combined two publicly available 'omics' databases to create a new catalogue of 'cancer drivers'. Cancer drivers are ...

Genetic drivers of immune response to cancer discovered through 'big data' analysis

July 18, 2016
Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified over 100 new genetic regions that affect the immune response to cancer. The findings, published in Cancer Immunology Research, could ...

Sequencing prostate tumors from African-American men reveals a novel tumor suppressor gene

May 19, 2017
African-American men develop prostate cancer more often than other men, and it tends to be more deadly for this population. Some of the differences seem to be due to socioeconomic factors, but scientists wondered whether ...

Researchers home in on mutation profiles of clear cell endometrial cancer

May 9, 2017
In the largest genomics study of clear cell endometrial cancer (CCEC) tumors to date, National Human Genome Research Institute (NHGRI) researchers and their collaborators have identified mutations in the TAF1 gene. They've ...

New statistical analysis reveals thousands of rare mutations linked with cancer

April 20, 2017
Scientists have identified thousands of previously ignored genetic mutations that, although rare, likely contribute to cancer growth. The findings, which could help pave the way to new treatments, are published in PLOS Computational ...

The silencer: Study reveals how a cancer gene promotes tumor growth

June 23, 2016
A Yale-led study describes how a known cancer gene, EGFR, silences genes that typically suppress tumors. The finding, published in Cell Reports, may lead to the development of more effective, individualized treatment for ...

Recommended for you

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.